A research team from the University of Samarra obtains a patent in cooperation with SDI, the first of its kind in Iraq
In the context of strengthening scientific and research cooperation between the University of Samarra and the Company for the Pharmaceutical Industry and Medical Appliances / Samarra, which was founded by the President of Samarra University, Professor Dr. Sabah Allawi Al-Samarrai with the management of the General Company for the Pharmaceutical Industry and Medical Supplies, A research team from the university and the general company obtained a patent in the bio-manufacturing of gold nanoparticles using the extract of the Tirmania Nivea mushroom.
The researchers included the preparation of gold nanoparticles (AuNPs) for the first time using Iraqi truffle extract by the Biosynthesis method detection and analysis were carried out using modern and advanced analysis devices (such as SEM scanning electron microscope, TEM transmission electron microscope, AFM atomic force microscopy, and X-ray energy dispersal EXD) to confirm and prove the presence of gold nanoparticles manufactured from truffle mushrooms.
The results showed the high effectiveness of the truffle extract in reducing the gold salt to gold nanoparticles, and this method is easy to manufacture, inexpensive, and not harmful to the environment. The effect of gold nanoparticles (AuNPs) on species of pathogenic bacteria (Pseudomonas aeruginous, and Escherichia coli) was studied. coli, Staphylococcus aureus, and Bacillus pumilus), and a type of yeast called Candida Albicans. The results showed high efficacy in inhibiting the growth of these types of harmful microorganisms.
The President of the University addressed a letter of appreciation to the research team who followed and supervised all stages of the work.
